Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
As noticed by many other colleagues, ICAAC 2015 was a shadow of its former self. Few participants overall, fewer posters, and even fewer exhibitors. Reviewing the posters, there were relatively few from industry, most came from university or small research labs. In a way, ICAAC 2015 was a true reflection of Continue reading Two New Antifungals Presented at ICAAC San Diego
When a well-designed pivotal Phase 3 trial fails to show NI, it demands an explanation. While awaiting the company’s analysis of the data, many possible explanations are bandied about. So it was not surprising that the eravacycline cUTI study (IGNITE-2) was mentioned quite often during ICAAC 2015, in sessions and Continue reading After ICAAC: Some More Thoughts on Eravacycline in cUTI and IGNITE-2
After the first 100 blogs, it is appropriate to reflect on reader preferences. When I arbitrarily select a topic, it is not always clear whether what interests me also interests you. Since its start 1½ years ago, this blog has grown steadily in readership. So we did a few things right Continue reading ALLPHASE PHARMA – THE FIRST 100 BLOG POSTS